Cytokinetics, Incorporated Collaboration Agreements
12 Contracts & Agreements
- License and Collaboration Agreement, dated December 20, 2021, by and between the Company and Ji Xing Pharmaceuticals Limited (Filed With SEC on February 25, 2022)
- Letter Agreement, dated December 23, 2020, by and between Company and Astellas amending the License and Collaboration Agreement for Other Skeletal Sarcomere Activators, dated... (Filed With SEC on February 26, 2021)
- License and Collaboration Agreement, dated July 14, 2020, by and between the Company and Ji Xing Pharmaceuticals Limited (Filed With SEC on November 6, 2020)
- Amendment No. 9, dated February 6, 2019, to the Collaboration and Option Agreement by and between the Company and Amgen Inc (Filed With SEC on March 7, 2019)
- Amendment No. 8, dated November 30, 2016, to the Collaboration and Option Agreement by and between the Company and Amgen Inc (Filed With SEC on March 7, 2019)
- Amendment to Collaboration Agreement; Joint Development Committee Membership (Filed With SEC on August 7, 2018)
- Amendment to Collaboration Agreement between the Company and Astellas Pharma Inc., dated December 21, 2017 (Filed With SEC on March 5, 2018)
- AMENDMENT TO THE AMENDED AND RESTATED LICENSE AND COLLABORATION AGREEMENT (Filed With SEC on November 3, 2016)
- AMENDMENT NO. 7 TO COLLABORATION AND OPTION AGREEMENT (Filed With SEC on May 4, 2015)
- Amended andRestated License and Collaboration Agreement by and between Cytokinetics, Inc. and Astellas Pharma Inc. (Filed With SEC on March 6, 2015)
- AMENDMENT NO. 6 TO COLLABORATION AND OPTION AGREEMENT (Filed With SEC on August 7, 2013)
- Amendment No. 2 To Collaboration Agreement (Filed With SEC on March 14, 2005)
